Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Scalable Graphene/Sn-WSe<sub>2</sub>/Si Photodetector Array With Broadband Response and Starlight Sensitivity for All-Light Vision.

Small (Weinheim an der Bergstrasse, Germany)·2026
Same author

The ITCC-P4 PDX Platform Enables Preclinical Testing of Pediatric Cancers.

Cancer research·2026
Same author

Frequency and Prognostic Significance of Genetic Abnormalities in a Subgroup of Patients With Intermediate-Risk Neuroblastoma: A SIOPEN Study.

JCO precision oncology·2026
Same author

Effect of La and Ce Microalloying on the Corrosion Resistance of 0.4Sb Low-Alloy Steel in a Harsh Marine Atmospheric Environment.

Materials (Basel, Switzerland)·2026
Same author

Anti-Tumor Activity of Cdk2/9 Inhibitor Fadraciclib in an In Vivo Model of Temozolomide Refractory Neuroblastoma.

Molecular cancer therapeutics·2026
Same author

Pterostilbene mitigates intervertebral disc degeneration via dual regulation of mitophagy and NLRP3 ubiquitination to inhibit nucleus pulposus cell pyroptosis.

Phytomedicine : international journal of phytotherapy and phytopharmacology·2026

相关实验视频

Updated: Sep 15, 2025

Zebrafish Model of Neuroblastoma Metastasis
05:20

Zebrafish Model of Neuroblastoma Metastasis

Published on: March 14, 2021

2.9K

对神经母细胞瘤的诊断技术

Leena Khelifa1, Yubing Hu1, Jennifer Tall2

  • 1Department of Chemical Engineering, Imperial College London, South Kensington, London, SW7 2BU, UK. yubing.hu@imperial.ac.uk.

Lab on a chip
|July 14, 2025
PubMed
概括

护理点 (POC) 诊断为早期神经母细胞瘤检测提供了一种非侵入性方法. 这些快速,具有成本效益的生物传感器技术通过识别血液或尿液中的生物标志物来改善风险分层和患者的结果.

更多相关视频

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

2.1K
Utilization of Ultrasound Guided Tissue-directed Cellular Implantation for the Establishment of Biologically Relevant Metastatic Tumor Xenografts
07:50

Utilization of Ultrasound Guided Tissue-directed Cellular Implantation for the Establishment of Biologically Relevant Metastatic Tumor Xenografts

Published on: May 25, 2018

8.4K

相关实验视频

Last Updated: Sep 15, 2025

Zebrafish Model of Neuroblastoma Metastasis
05:20

Zebrafish Model of Neuroblastoma Metastasis

Published on: March 14, 2021

2.9K
Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

2.1K
Utilization of Ultrasound Guided Tissue-directed Cellular Implantation for the Establishment of Biologically Relevant Metastatic Tumor Xenografts
07:50

Utilization of Ultrasound Guided Tissue-directed Cellular Implantation for the Establishment of Biologically Relevant Metastatic Tumor Xenografts

Published on: May 25, 2018

8.4K

科学领域:

  • 儿科瘤学 儿科瘤学
  • 生物医学工程 生物医学工程
  • 诊断技术 诊断技术的使用

背景情况:

  • 神经母细胞瘤是一种具有高复发率和异质性的侵袭性儿童癌症.
  • 目前的诊断方法,包括活检,导致患者严重的创伤,并且经常无法在早期,切除的阶段检测出瘤.
  • 现有的诊断技术缺乏早期和广泛查所需的速度和非侵入性.

研究的目的:

  • 审查神经母细胞瘤诊断方面的进展,重点关注快速,非侵入性和成本有效的方法.
  • 突出点护理 (POC) 诊断设备在早期神经母细胞瘤检测和风险分层方面的潜力.
  • 讨论新生物标志物在神经母细胞瘤中POC应用的翻译潜力.

主要方法:

  • 关于神经母细胞瘤诊断技术的最新文献的审查,包括液体活检,放射学,人工智能和生物传感器.
  • 对新兴生物标记物的分析,如蛋白质组,代谢和表观遗传标记 (例如,MYCN放大,微RNA).
  • 对用于神经母细胞瘤查的POC诊断设备的可行性和潜力的评估.

主要成果:

  • 液体活检,放射学,人工智能和生物传感器等进展正在推动开发更快,非侵入性诊断工具.
  • 几种潜在的生物标志物 (蛋白质,代谢,表观遗传) 显示出在生物流体中POC检测的前景.
  • POC诊断为早期人口水平查和家庭健康监测神经母细胞瘤提供了一条途径.

结论:

  • 通过血液和尿液中的生物标志物,POC诊断设备具有非侵入性,早期检测神经母细胞瘤的巨大潜力.
  • 这些技术可以促进早期查,风险分层和实时健康监测,改善患者的治疗结果.
  • 需要对现有的POC设备进行进一步的临床验证,以便在神经母细胞瘤诊断和管理中充分发挥其潜力.